Searchable abstracts of presentations at key conferences in endocrinology

ea0036P45 | (1) | BSPED2014

Using an electronic tablet to survey patient satisfaction in an adolescent transitional diabetes clinic at York, United Kingdom

Joy Reeba , Smith Dominic , Mannion Joanne

Objectives: To assess patient satisfaction with the transitional diabetes clinic service. Our transitional diabetes clinics (for 14–19 year olds) are run monthly by a multi disciplinary team comprising of a consultant, nurse and dietician each, from both adult and paediatric diabetes teams.Methods: An electronic tablet with the pre-programmed survey was handed out to 42 young people while they were waiting to be seen in clinic.<p class="abstext"...

ea0034p48 | Clinical biochemistry | SFEBES2014

Development of a whole blood assay for the LC–MS/MS measurement of 5-hydroxyindole acetic acid

Armitage Suzanne , Adaway Joanne , Keevil Brian

Background: 5-hydroxyindole acetic acid (5-HIAA), a metabolite of serotonin, is used as a marker for patients with serotonin-secreting neuroendocrine tumours (NET). Currently, the majority of laboratories measure 5-HIAA excretion in 24 h urine samples. Given the practicality and analytic problems of these samples, our laboratory successfully developed a LC–MS/MS method for the analysis of 5-HIAA in serum samples. Further to this, we have now developed a method to measure ...

ea0028p146 | Neoplasia, cancer and late effects | SFEBES2012

Physiological levels of soy isoflavones inhibit the growth of oestrogen receptor β-positive but not α-positive breast cancer cells

Wallace Joanne , Gow Iain , Warnock Mary

The biphasic effect of soy isoflavones (genistein and daidzein) on oestrogen receptor (ER)α+ breast cancer cell proliferation is well documented, with concentrations of ≤10 µM promoting proliferation, and growth inhibitory and apoptotic effects seen at concentrations ≥10 µM. However genistein concentrations as low as 1nM may inhibit the proliferation of some ERα-/β+ cells. This is at odds with epidemiological evidence ...

ea0025p333 | Thyroid | SFEBES2011

Audit of thyroid function testing in patients on amiodarone

Srinivas Vidya , Srinivasan Ramalingam , Randall Joanne

Objective: Amiodarone is an iodine rich, potent antiarrhythmic drug that is highly lipid soluble and total body iodine stores remain increased for up to 9 months. Abnormal thyroid functions, either thyrotoxicosis or hypothyroidism occur in upto 14–18% of patients receiving long-term amiodarone therapy. Hence regular thyroid function tests are required in patients on long-term amiodarone treatment. The BNF clearly states that thyroid function tests should be done at a mini...

ea0095oc6.5 | Oral Communications 6 | BSPED2023

Growth hormone excess in children with pituitary adenomas associated with endocrine syndromes

Park Julie , Daousi Christina , Blair Joanne

Growth hormone (GH) excess is extremely rare in children. It can be associated with endocrine syndromes including MEN1, Carney complex and Mc Cune Albright syndrome. We describe two cases of GH excess and their management. Patient A (15yr M) presented with fibrous dysplasia affecting his cranium and a large café-au-lait spot covering his right scapula. His height was 193cm (2.6 SDS) and BMI 29.6kg/m2(2.3SDS). His IGF1 was 84.1nmol/L (22.5 – 65.9) and GH did not suppr...

ea0078p2 | Adrenal | BSPED2021

Glucose regulation and cardiovascular health in children and young people (CYP) with primary adrenal insufficiency: preliminary data (GRACE study)

Park Julie , Hawcutt Daniel , Shantsila Alena , Lip Gregory , Blair Joanne

Background: The cardiovascular and metabolic outcomes of patients with AI are poor, and may be related to the non-physiological cortisol profile achieved with hydrocortisone treatment. Objectives: To describe salivary adrenal biomarkers, glucose and 24 hour ambulatory blood pressure (ABP) profiles, carotid intima media thickness (CIMT) and flow mediated dilatation (FMD) in CYP with primary AI, to improve knowledge of the relationship between non-physiolo...

ea0050p004 | Adrenal and Steroids | SFEBES2017

Development of a liquid chromatography tandem mass spectrometry assay for the profiling of salivary androgens and gestagens

Adaway Joanne E , Schiffer Lina , Arlt Wiebke , Keevil Brian G

Measuring circulating androgen and gestagen concentrations is essential for the diagnosis and treatment monitoring of pathological conditions caused by abnormal steroidogenesis, such as congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS). Saliva collection represents a simple and non-invasive technique advantageous for multi sample profiling. We therefore developed a liquid chromatography-tandem mass spectrometry assay for the s...

ea0050p183 | Clinical Biochemistry | SFEBES2017

The free androgen index in women is inaccurate when the SHBG concentration is low

Keevil Brian , Adaway Joanne , Fiers Tom , Kaufman Jean-Marc

Introduction: Current clinical practice guidelines recognise that a calculated free testosterone (T) level is the single most-useful, clinically sensitive marker of androgen excess in women, but there is no clear guidance as to the best way to measure free T. Several equations have been proposed to calculate clinically useful estimates of free T including the free androgen index (FAI) and calculated free T (cFT). The FAI is not used in men but it is...

ea0050p004 | Adrenal and Steroids | SFEBES2017

Development of a liquid chromatography tandem mass spectrometry assay for the profiling of salivary androgens and gestagens

Adaway Joanne E , Schiffer Lina , Arlt Wiebke , Keevil Brian G

Measuring circulating androgen and gestagen concentrations is essential for the diagnosis and treatment monitoring of pathological conditions caused by abnormal steroidogenesis, such as congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS). Saliva collection represents a simple and non-invasive technique advantageous for multi sample profiling. We therefore developed a liquid chromatography-tandem mass spectrometry assay for the s...

ea0050p183 | Clinical Biochemistry | SFEBES2017

The free androgen index in women is inaccurate when the SHBG concentration is low

Keevil Brian , Adaway Joanne , Fiers Tom , Kaufman Jean-Marc

Introduction: Current clinical practice guidelines recognise that a calculated free testosterone (T) level is the single most-useful, clinically sensitive marker of androgen excess in women, but there is no clear guidance as to the best way to measure free T. Several equations have been proposed to calculate clinically useful estimates of free T including the free androgen index (FAI) and calculated free T (cFT). The FAI is not used in men but it is...